<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3412624/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412624/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical cancer research : an official journal of the American Association for Cancer Research"><meta name="citation_title" content="A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303"><meta name="citation_authors" content="Federico Innocenti, Kouros Owzar, Nancy L. Cox, Patrick Evans, Michiaki Kubo, Hitoshi Zembutsu, Chen Jiang, Donna Hollis, Taisei Mushiroda, Liang Li, Paula Friedman, Liewei Wang, Dylan Glubb, Herbert Hurwitz, Kathleen M. Giacomini, Howard L. McLeod, Richard M. Goldberg, Richard L. Schilsky, Hedy L. Kindler, Yusuke Nakamura, Mark J. Ratain"><meta name="citation_date" content="15 January 2012"><meta name="citation_issue" content="2"><meta name="citation_volume" content="18"><meta name="citation_firstpage" content="577"><meta name="citation_doi" content="10.1158/1078-0432.CCR-11-1387"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3412624/?report=abstract"><meta name="citation_pmid" content="22142827"><meta name="DC.Title" content="A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Federico Innocenti"><meta name="DC.Contributor" content="Kouros Owzar"><meta name="DC.Contributor" content="Nancy L. Cox"><meta name="DC.Contributor" content="Patrick Evans"><meta name="DC.Contributor" content="Michiaki Kubo"><meta name="DC.Contributor" content="Hitoshi Zembutsu"><meta name="DC.Contributor" content="Chen Jiang"><meta name="DC.Contributor" content="Donna Hollis"><meta name="DC.Contributor" content="Taisei Mushiroda"><meta name="DC.Contributor" content="Liang Li"><meta name="DC.Contributor" content="Paula Friedman"><meta name="DC.Contributor" content="Liewei Wang"><meta name="DC.Contributor" content="Dylan Glubb"><meta name="DC.Contributor" content="Herbert Hurwitz"><meta name="DC.Contributor" content="Kathleen M. Giacomini"><meta name="DC.Contributor" content="Howard L. McLeod"><meta name="DC.Contributor" content="Richard M. Goldberg"><meta name="DC.Contributor" content="Richard L. Schilsky"><meta name="DC.Contributor" content="Hedy L. Kindler"><meta name="DC.Contributor" content="Yusuke Nakamura"><meta name="DC.Contributor" content="Mark J. Ratain"><meta name="DC.Date" content="2012 Jan 15"><meta name="DC.Identifier" content="10.1158/1078-0432.CCR-11-1387"><meta name="DC.Language" content="en"><meta property="og:title" content="A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303"><meta property="og:type" content="article"><meta property="og:description" content="CALGB 80303 was a randomized, phase III study in advanced pancreatic cancer patients treated with gemcitabine plus either bevacizumab or placebo. We prospectively collected germline DNA and conducted a genome-wide association study (GWAS) using overall ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412624/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3412624/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3412624/pdf/nihms341305.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8CB9E0DD53BE810000000000630041.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3412624%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3412624</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Clin Cancer Res</a></span>. Author manuscript; available in PMC 2013 Jan 15.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22142827" target="pmc_ext" ref="reftype=publisher&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Clin Cancer Res. 2012 Jan 15; 18(2): 577–584. </span></a></div><span class="fm-vol-iss-date">Published online 2011 Dec 5. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1158%2F1078-0432.CCR-11-1387" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/1078-0432.CCR-11-1387</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3412624</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS341305</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22142827">22142827</a></div></div></div></div><h1 class="content-title">A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Innocenti%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958061706000" co-class="co-affbox">Federico Innocenti</a>,<sup>1</sup> <a href="/pubmed/?term=Owzar%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958098992304" co-class="co-affbox">Kouros Owzar</a>,<sup>2</sup> <a href="/pubmed/?term=Cox%20NL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958098990080" co-class="co-affbox">Nancy L. Cox</a>,<sup>1</sup> <a href="/pubmed/?term=Evans%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958052009136" co-class="co-affbox">Patrick Evans</a>,<sup>1</sup> <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958040968736" co-class="co-affbox">Michiaki Kubo</a>,<sup>3</sup> <a href="/pubmed/?term=Zembutsu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958059652656" co-class="co-affbox">Hitoshi Zembutsu</a>,<sup>3</sup> <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958135839584" co-class="co-affbox">Chen Jiang</a>,<sup>2</sup> <a href="/pubmed/?term=Hollis%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958055978624" co-class="co-affbox">Donna Hollis</a>,<sup>2</sup> <a href="/pubmed/?term=Mushiroda%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958049049040" co-class="co-affbox">Taisei Mushiroda</a>,<sup>3</sup> <a href="/pubmed/?term=Li%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958049046816" co-class="co-affbox">Liang Li</a>,<sup>4</sup> <a href="/pubmed/?term=Friedman%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958062358672" co-class="co-affbox">Paula Friedman</a>,<sup>5</sup> <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958054832992" co-class="co-affbox">Liewei Wang</a>,<sup>4</sup> <a href="/pubmed/?term=Glubb%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958052113104" co-class="co-affbox">Dylan Glubb</a>,<sup>1</sup> <a href="/pubmed/?term=Hurwitz%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958059439168" co-class="co-affbox">Herbert Hurwitz</a>,<sup>6</sup> <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958060911104" co-class="co-affbox">Kathleen M. Giacomini</a>,<sup>7</sup> <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958060908880" co-class="co-affbox">Howard L. McLeod</a>,<sup>8</sup> <a href="/pubmed/?term=Goldberg%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958057448064" co-class="co-affbox">Richard M. Goldberg</a>,<sup>9</sup> <a href="/pubmed/?term=Schilsky%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958061728576" co-class="co-affbox">Richard L. Schilsky</a>,<sup>1</sup> <a href="/pubmed/?term=Kindler%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958098937056" co-class="co-affbox">Hedy L. Kindler</a>,<sup>1</sup> <a href="/pubmed/?term=Nakamura%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958137178176" co-class="co-affbox">Yusuke Nakamura</a>,<sup>3</sup> and  <a href="/pubmed/?term=Ratain%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827" class="affpopup" co-rid="_co_idm139958055427408" co-class="co-affbox">Mark J. Ratain</a><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139958061706000"><h3 class="no_margin">Federico Innocenti</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Innocenti%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Federico Innocenti</a></div></div><div id="_co_idm139958098992304"><h3 class="no_margin">Kouros Owzar</h3><p><sup>2</sup>Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Owzar%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Kouros Owzar</a></div></div><div id="_co_idm139958098990080"><h3 class="no_margin">Nancy L. Cox</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Cox%20NL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Nancy L. Cox</a></div></div><div id="_co_idm139958052009136"><h3 class="no_margin">Patrick Evans</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Evans%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Patrick Evans</a></div></div><div id="_co_idm139958040968736"><h3 class="no_margin">Michiaki Kubo</h3><p><sup>3</sup>Center for Genomic Medicine, RIKEN, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Michiaki Kubo</a></div></div><div id="_co_idm139958059652656"><h3 class="no_margin">Hitoshi Zembutsu</h3><p><sup>3</sup>Center for Genomic Medicine, RIKEN, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Zembutsu%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Hitoshi Zembutsu</a></div></div><div id="_co_idm139958135839584"><h3 class="no_margin">Chen Jiang</h3><p><sup>2</sup>Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Chen Jiang</a></div></div><div id="_co_idm139958055978624"><h3 class="no_margin">Donna Hollis</h3><p><sup>2</sup>Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Hollis%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Donna Hollis</a></div></div><div id="_co_idm139958049049040"><h3 class="no_margin">Taisei Mushiroda</h3><p><sup>3</sup>Center for Genomic Medicine, RIKEN, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Mushiroda%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Taisei Mushiroda</a></div></div><div id="_co_idm139958049046816"><h3 class="no_margin">Liang Li</h3><p><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="/pubmed/?term=Li%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Liang Li</a></div></div><div id="_co_idm139958062358672"><h3 class="no_margin">Paula Friedman</h3><p><sup>5</sup>Cancer and Leukemia Group B (CALGB), University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Friedman%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Paula Friedman</a></div></div><div id="_co_idm139958054832992"><h3 class="no_margin">Liewei Wang</h3><p><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA</p><div>Find articles by <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Liewei Wang</a></div></div><div id="_co_idm139958052113104"><h3 class="no_margin">Dylan Glubb</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Glubb%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Dylan Glubb</a></div></div><div id="_co_idm139958059439168"><h3 class="no_margin">Herbert Hurwitz</h3><p><sup>6</sup>Department of Medicine, Duke University Medical Center, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Hurwitz%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Herbert Hurwitz</a></div></div><div id="_co_idm139958060911104"><h3 class="no_margin">Kathleen M. Giacomini</h3><p><sup>7</sup>Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, CA, USA</p><div>Find articles by <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Kathleen M. Giacomini</a></div></div><div id="_co_idm139958060908880"><h3 class="no_margin">Howard L. McLeod</h3><p><sup>8</sup>Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina, Chapel Hill, NC, USA</p><div>Find articles by <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Howard L. McLeod</a></div></div><div id="_co_idm139958057448064"><h3 class="no_margin">Richard M. Goldberg</h3><p><sup>9</sup>Department of Medicine, University of North Carolina, Chapel Hill, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Goldberg%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Richard M. Goldberg</a></div></div><div id="_co_idm139958061728576"><h3 class="no_margin">Richard L. Schilsky</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Schilsky%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Richard L. Schilsky</a></div></div><div id="_co_idm139958098937056"><h3 class="no_margin">Hedy L. Kindler</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Kindler%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Hedy L. Kindler</a></div></div><div id="_co_idm139958137178176"><h3 class="no_margin">Yusuke Nakamura</h3><p><sup>3</sup>Center for Genomic Medicine, RIKEN, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Nakamura%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Yusuke Nakamura</a></div></div><div id="_co_idm139958055427408"><h3 class="no_margin">Mark J. Ratain</h3><p><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</p><div>Find articles by <a href="/pubmed/?term=Ratain%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22142827">Mark J. Ratain</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139958057844160_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139958057844160_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139958057844160_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Medicine, University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center, Durham, NC, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Center for Genomic Medicine, RIKEN, Tokyo, Japan</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Cancer and Leukemia Group B (CALGB), University of Chicago, Chicago, IL, USA</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Department of Medicine, Duke University Medical Center, Durham, NC, USA</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, CA, USA</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina, Chapel Hill, NC, USA</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Department of Medicine, University of North Carolina, Chapel Hill, NC, USA</div><div id="cor1"><strong>Correspondence:</strong> Federico Innocenti, M.D., Ph.D., Associate Professor, University of North Carolina at Chapel Hill, Institute for Pharmacogenomics and Individualized Therapy, 1014 Genetic Medicine Bldg., CB 7361, 120 Mason Farm Rd., Chapel Hill, NC 27599-7361, Tel 919-966-9422, Fax 919-966-5863, <a href="mailto:dev@null" data-email="ude.cnu@tneconni" class="oemail">ude.cnu@tneconni</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139958057844160_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22142827" target="pmc_ext" ref="reftype=publisher&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Clin Cancer Res</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3412624/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC3412624/bin/NIHMS341305-supplement-1.doc" data-ga-action="click_feat_suppl">NIHMS341305-supplement-1.doc</a><span style="color:gray"> (182K)</span></div><div class="small guid">GUID:&nbsp;F6E03FA3-F87D-4F77-9C42-BDE0F925413E</div></div></dd></dl></div><div id="idm139958060331392" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139958060331392title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background and Aims</h3><p id="P1" class="p p-first-last">CALGB 80303 was a randomized, phase III study in advanced pancreatic cancer patients treated with gemcitabine plus either bevacizumab or placebo. We prospectively collected germline DNA and conducted a genome-wide association study (GWAS) using overall survival (OS) as the endpoint.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">DNA from 351 patients was genotyped for &gt;550,000 single nucleotide polymorphisms (SNPs). Associations between OS and SNPs were investigated using the log-linear two-way multiplicative Cox proportional-hazards model. The subset of 294 genetically European patients was used for the primary analysis.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">A nonsynonymous SNP in <em>IL17F</em> (rs763780, H161R) and an intronic SNP in strong linkage disequilibrium (rs7771466) were associated with OS using genome-wide criteria (p≤10<sup>−7</sup>). Median OS was significantly shorter (p 2.61×10<sup>−8</sup>) for the rs763780 heterozygotes (3.1 months, 95% CI 2.3–4.3) as compared to the patients without this variant (6.8 months, 5.8–7.3). After adjustment by stratification factors, the p value for the association was 9.51×10<sup>−7</sup>.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last">The variant 161R form of interleukin-17F is a natural antagonist of the anti-angiogenic effects of wild-type 161H interleukin-17F, and angiogenesis may play an important role in the metastatic spread of pancreatic cancer. In this preliminary study, we hypothesize that the angiogenesis potential of pancreatic cancers in patients with variant interleukin-17F is higher than that of tumors in patients with wild-type interleukin-17F, conferring worse prognosis. This exploratory GWAS may provide the foundation for testing the biology and clinical effects of novel genes and their heritable variants through mechanistic and confirmatory studies in pancreatic cancer.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">GWAS, pharmacogenetics, bevacizumab, pancreatic cancer, gemcitabine</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">INTRODUCTION</h2><p id="P5" class="p p-first">Pancreatic cancer has a very poor prognosis and the lowest survival by stage of any solid tumor[<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071087" role="button" aria-expanded="false" aria-haspopup="true">1</a>]. Gemcitabine is the cornerstone of chemotherapy in this disease but has a very modest impact[<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071062" role="button" aria-expanded="false" aria-haspopup="true">2</a>], and although numerous clinical trials have been conducted, only the combination of gemcitabine and erlotinib achieved a modest increase in median OS over gemcitabine alone[<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071068" role="button" aria-expanded="false" aria-haspopup="true">3</a>]. Novel agents and/or novel molecular biomarkers are urgently needed. One approach is to identify novel candidate genes putatively involved in the biology of pancreatic cancer.</p><p id="P6">It is likely that germline variants will be able to predict the outcome of patients with cancer and there is epidemiologic evidence that prognosis has an inherited component[<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071057" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. To test this, we conducted a genome-wide association study (GWAS) in Cancer and Leukemia Group B (CALGB) study 80303, a randomized, double-blind, phase III study in 602 advanced pancreatic cancer patients treated with gemcitabine plus either bevacizumab or placebo. There was no superiority in OS of the gemcitabine-bevacizumab arm compared to the gemcitabine-placebo arm[<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071074" role="button" aria-expanded="false" aria-haspopup="true">5</a>].</p><p id="P7" class="p p-last">As part of the study, we prospectively collected germline DNA for pharmacogenetic studies, originally focusing on the association of candidate genes with treatment outcome. We subsequently amended the study to conduct a genome-wide association study (GWAS) in order to identify novel associations. In GWAS, germline DNA of patients can be scanned using high-density single-nucleotide polymorphism (SNP) chips that assess hundreds of thousands of SNP markers[<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071077" role="button" aria-expanded="false" aria-haspopup="true">6</a>]. This approach is unbiased and does not rely on a priori knowledge about the role of candidate markers for the outcome of interest. The goal of this study was to identify novel genes associated with OS in pancreatic cancer.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">PATIENTS AND METHODS</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Clinical trial and patients</h3><p id="P8" class="p p-first">CALGB 80303 was a double-blind, placebo-controlled randomized (1:1) phase III multi-institution study of bevacizumab, in combination with gemcitabine. Eligible patients had histologically or cytologically confirmed adenocarcinoma of the pancreas not amenable to potentially curative surgery, as previously described[<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071064" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. Patients were required to have an ECOG performance status of 0–2 and adequate bone marrow, renal, and hepatic function. Gemcitabine 1000 mg/m<sup>2</sup> was given intravenously over 30 min on days 1, 8, and 15 of a 28-day cycle. Bevacizumab, 10 mg/kg, or placebo was administered intravenously after gemcitabine on days 1 and 15 of each 28-day cycle. Treatment was discontinued for progressive disease, unacceptable adverse events, or patient withdrawal of consent.</p><p id="P9">Patients were stratified according to extent of disease (locally advanced vs. metastatic), ECOG performance status (0–1, vs. 2) and prior radiotherapy (yes/no). Patients received a minimum of two cycles of treatment unless unacceptable toxicity or early progression of disease occurred. Patients were evaluated for response according to the Response Evaluation Criteria in Solid Tumors[<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071080" role="button" aria-expanded="false" aria-haspopup="true">8</a>] every 2 cycles. Confirmatory scans were obtained at least 4 weeks following initial documentation of objective complete or partial response. OS, with date of randomization as its reference point, was the primary study endpoint.</p><p id="P10" class="p p-last">The companion pharmacogenetic protocol (CALGB 60401) was approved by the Institutional Review Boards of the University of Chicago and the Riken Institute. Only patients who consented to CALGB 60401 were included in this study. The patient and tumor characteristics of the subgroup of patients genotyped in this study are comparable to those of patients in the main clinical trial (<a href="/pmc/articles/PMC3412624/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="P43">Patient demographics.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139958058644128" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center">All Patients</th><th rowspan="1" colspan="1" align="center">GWAS Patients</th><th rowspan="1" colspan="1" align="center">GWAS Patients of<br>European Ancestry</th><th rowspan="1" colspan="1" align="center">GWAS Patients of<br>African Ancestry</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="center"><strong>Sample Size</strong></td><td rowspan="1" colspan="1" align="center"></td><td rowspan="1" colspan="1" align="center">602</td><td rowspan="1" colspan="1" align="center">338</td><td rowspan="1" colspan="1" align="center">294</td><td rowspan="1" colspan="1" align="center">26</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Sex</strong></td><td rowspan="1" colspan="1" valign="top" align="center">Male</td><td rowspan="1" colspan="1" valign="top" align="center">329</td><td rowspan="1" colspan="1" valign="top" align="center">185</td><td rowspan="1" colspan="1" valign="top" align="center">159</td><td rowspan="1" colspan="1" valign="top" align="center">15</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Female</td><td rowspan="1" colspan="1" valign="top" align="center">273</td><td rowspan="1" colspan="1" valign="top" align="center">153</td><td rowspan="1" colspan="1" valign="top" align="center">135</td><td rowspan="1" colspan="1" valign="top" align="center">11</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Age</strong></td><td rowspan="1" colspan="1" valign="top" align="center">Mean (SD)</td><td rowspan="1" colspan="1" valign="top" align="center">64.0 (10.6)</td><td rowspan="1" colspan="1" valign="top" align="center">63.6(10.4)</td><td rowspan="1" colspan="1" valign="top" align="center">63.8 (10.5)</td><td rowspan="1" colspan="1" valign="top" align="center">62.0 (8.5)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Median<br>(95%CI)</td><td rowspan="1" colspan="1" valign="top" align="center">64.1<br>(63.2–65.1)</td><td rowspan="1" colspan="1" valign="top" align="center">64<br>(62.8–65.2)</td><td rowspan="1" colspan="1" valign="top" align="center">64<br>(63.0–65.5)</td><td rowspan="1" colspan="1" valign="top" align="center">64<br>(60.9–67.1)</td></tr><tr><td rowspan="7" colspan="1" valign="middle" align="center"><strong>Race</strong></td><td rowspan="1" colspan="1" valign="top" align="center">White</td><td rowspan="1" colspan="1" valign="top" align="center">529 (87.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">301 (89.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">289 (98.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Black</td><td rowspan="1" colspan="1" valign="top" align="center">49 (8.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">26 (7.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">26 (100%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Asian</td><td rowspan="1" colspan="1" valign="top" align="center">10 (1.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">2 (0.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Native Hawaiian</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">American Indian</td><td rowspan="1" colspan="1" valign="top" align="center">3 (0.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Multiple</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">1 (0.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Unknown</td><td rowspan="1" colspan="1" valign="top" align="center">9 (1.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">7 (2.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">5 (1.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Extent of</strong><br><strong>Disease</strong></td><td rowspan="1" colspan="1" valign="top" align="center">Metastatic</td><td rowspan="1" colspan="1" valign="top" align="center">520 (86.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">299 (88.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">256 (87.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">25 (96.2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Locally Advanced</td><td rowspan="1" colspan="1" valign="top" align="center">69 (11.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">39 (11.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">38 (12.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">1 (3.8%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Prior</strong><br><strong>Radiotherapy</strong></td><td rowspan="1" colspan="1" valign="top" align="center">No</td><td rowspan="1" colspan="1" valign="top" align="center">526 (87.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">302 (89.3%)</td><td rowspan="1" colspan="1" valign="top" align="center">262 (89.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">26 (92.3%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Yes</td><td rowspan="1" colspan="1" valign="top" align="center">65 (10.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">36 (10.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">32 (10.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">2 (7.7%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Performance</strong><br><strong>Status</strong></td><td rowspan="1" colspan="1" valign="top" align="center">0 or 1</td><td rowspan="1" colspan="1" valign="top" align="center">537 (89.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">305 (90.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">265 (90.1%)</td><td rowspan="1" colspan="1" valign="top" align="center">23 (88.5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">65 (10.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">33 (9.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">29 (9.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">3 (11.5%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>Arm</strong></td><td rowspan="1" colspan="1" valign="top" align="center">Placebo</td><td rowspan="1" colspan="1" valign="top" align="center">300 (49.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">157 (46.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">140 (47.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">9 (34.6%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Bevacizumab</td><td rowspan="1" colspan="1" valign="top" align="center">302 (50.2%)</td><td rowspan="1" colspan="1" valign="top" align="center">181 (53.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">154 (52.4%)</td><td rowspan="1" colspan="1" valign="top" align="center">17 (65.4%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="center"><strong>OS time</strong></td><td rowspan="1" colspan="1" valign="top" align="center">Median (months)</td><td rowspan="1" colspan="1" valign="top" align="center">5.85</td><td rowspan="1" colspan="1" valign="top" align="center">5.86</td><td rowspan="1" colspan="1" valign="top" align="center">5.93</td><td rowspan="1" colspan="1" valign="top" align="center">5.83</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Mean (months)</td><td rowspan="1" colspan="1" valign="top" align="center">7.71</td><td rowspan="1" colspan="1" valign="top" align="center">7.75</td><td rowspan="1" colspan="1" valign="top" align="center">7.82</td><td rowspan="1" colspan="1" valign="top" align="center">8.07</td></tr></tbody></table></div><div id="largeobj_idm139958058644128" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3412624/table/T1/?report=objectonly">Open in a separate window</a></div></div></div><div id="S8" class="sec"><h3 id="S8title">DNA samples and genotyping platforms</h3><p id="P11" class="p p-first">Of the 602 randomized patients on the main clinical study[<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071063" role="button" aria-expanded="false" aria-haspopup="true">5</a>], blood samples were collected from 365 patients who consented to the pharmacogenetic analysis, and were shipped to the CALGB Pathology Coordinating Office (PCO) at Ohio State University. DNA was extracted from a single 5–10 ml peripheral whole blood sample collected using EDTA vacutainer tubes (purple tops) prior to beginning the study treatment using a commercially available kit from Qiagen (Germantown, MD). The concentration and quality of DNA were measured by ultraviolet spectrophotometry (Nanodrop, Wilmington, DE). DNA of sufficient yield and quality (i.e. at least 2.5 µg and a minimum concentration of 50 ng/ml) was obtained on 352 of the blood specimens (96%). DNA samples were randomly placed on a 96-deep well plate, each well containing one sample at a concentration of 50 ng/µl and volume of 50 µl (by dilution with dH<sub>2</sub>O if needed).</p><p id="P12" class="p p-last">The Illumina HumanHap550v3 Genotyping BeadChip was used to genotype &gt;550,000 SNPs in these samples. In addition, &gt;7,000 SNPs in 267 candidate (i.e., hypothesized <em>a priori</em> to be drug-related) genes were also genotyped in the same chip[<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071086" role="button" aria-expanded="false" aria-haspopup="true">9</a>]. Genotyping was conducted at the Center for Genomic Medicine, Riken Institute (Yokohama, Japan).</p></div><div id="S9" class="sec"><h3 id="S9title">Quality control of the genotyping results and the phenotypic data (<a href="/pmc/articles/PMC3412624/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>)</h3><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3412624/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139958065225856" class="figure"><a href="/pmc/articles/PMC3412624/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3412624_nihms341305f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms341305f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3412624/bin/nihms341305f1.jpg"></a></div><div id="largeobj_idm139958065225856" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3412624/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3412624/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Flow chart of the quality control process in 352 initial patients genotyped with 561,466 SNPs</strong><p id="P40">IBS, identity by state; MAF, minor relative allelic frequency; MGC, minor genotypic counts.</p></div></div></div><p id="P13" class="p p-first">Cases excluded from analysis were closely related patients. We assessed the relatedness among patients by IBS, and the only individual removed from the IBS was one set of duplicates (n=1) (as shown in <a href="/pmc/articles/PMC3412624/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Patients who were not treated or went off study before completing 2 cycles of therapy were also excluded (n=13). The remaining 338 patients formed the basis for the association analyses. Among the 561,466 SNPs typed on the platform, 44,108 SNPs were excluded due to call rates less than 95%. Among the remaining 517,538 SNPs, 21,894 SNPs with minor relative allelic frequencies (MAF) less than 0.01 were removed. Finally, among the 495,464 remaining SNPs, 88 SNPs with strong evidence for departure from Hardy-Weinberg equilibrium (HWE, p&lt;10<sup>−8</sup>) were removed. Among the 495,376 SNPs passing the filter, 484,523 were autosomal. Among these, 330,690 SNPs had a minor genotypic counts (MGC) &gt;9 and were used in the association analyses.</p><p id="P14" class="p p-last">Patient registration, data collection, and data analysis were performed by the CALGB Statistical Center. Data quality was ensured by careful review of data by CALGB Statistical Center staff and the study chairperson.</p></div><div id="S10" class="sec"><h3 id="S10title">Population structure analysis</h3><p id="P15" class="p p-first-last">Self-reported ethnicity information was available for each patient. However, this was confirmed by estimating the genetic ancestral origin of patients using the principal components analysis software implemented in Eigenstrat[<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071081" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. This was done by combining our case data with the European, Asian, and African population SNP data from HapMap. Genetically-European patients enrolled in CALGB 80303 were then selected by choosing only those individuals that closely clustered with the European HapMap samples when using all SNPs in the HumanHap550K BeadChip. This resulted in 294 patients of genetically-estimated European ancestry, and in 26 patients of genetically-estimated African ancestry (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material, Figure 1</a>). Also as shown in this figure, the CALGB 80303 samples lined up as expected against the reference HapMap samples. A strong concordance between genetically-estimated ancestry and self-reported race was observed.</p></div><div id="S11" class="sec"><h3 id="S11title">Functional studies</h3><p id="P16" class="p p-first-last">The putative functional effects of the 20 most significant SNPs associated with OS were examined using FastSNP (<a href="http://fastsnp.ibms.sinica.edu.tw/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://fastsnp.ibms.sinica.edu.tw/</a>), a web-based bioinformatic application[<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071070" role="button" aria-expanded="false" aria-haspopup="true">11</a>]. Fast SNP can identify genetic regulatory regions, non-synonymous and nonsense amino acid changes and determines the effects of SNPs on exon splicing enhancer and silencer motifs, and transcription factor binding sites. For the same purpose, we also have used our genome-wide data of gemcitabine cytotoxicity in lymphoblastoid cell lines[<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071060" role="button" aria-expanded="false" aria-haspopup="true">12</a>].</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Statistical analysis of the associations</h3><p id="P17" class="p p-first-last">Our primary analysis determined the association between SNPs and OS in both arms combined, in patients of European ancestry only. For the SNP by OS association analyses, the Cox score (log-rank) test was used, and the analyses were powered against the additive genetic model. The robustness of the genetic associations in the unadjusted analysis (i.e., our primary analysis described above) was tested by including covariates in the model, testing within the framework of a multivariable additive log-linear Cox proportional-hazards model[<a href="#R13" rid="R13" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>]. These covariates were: randomization stratification factors (performance status, prior radiotherapy, and extent of disease), treatment arm, and genetic ancestry (based on the three principal components). In the genome-wide feature selection process for the genetically European population, only SNPs with MGC&gt;9 were considered. The most significant SNP, <em>IL17F</em> rs763780 for OS in patients of European ancestry was also tested in the patients of African ancestry, in an unadjusted analysis. The coxph function from the R[<a href="#R13" rid="R13" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">13</a>] extension package survival[<a href="#R14" rid="R14" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">14</a>] was used. The p values were not adjusted for multiple comparisons. For a Q-Q plot, see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material</a> (<a href="/pmc/articles/PMC3412624/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). We have used 1×10<sup>−7</sup> (0.05/500,000) as the p value cut-off for genome-wide significance.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3412624/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139958056916304" class="figure"><a href="/pmc/articles/PMC3412624/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3412624_nihms341305f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms341305f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3412624/bin/nihms341305f2.jpg"></a></div><div id="largeobj_idm139958056916304" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3412624/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3412624/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Manhattan plot of SNPs associated with OS in patients of European ancestry with both arms combined</strong><p id="P41">The observed marginal P-values (minus log base 10 scale) are plotted across the chromosomes.</p></div></div></div></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">RESULTS</h2><p id="P18" class="p p-first">The OS (median, 95% CI) in the genotyped patients of European ancestry was 6.3 months (5.1–8.0) in the placebo arm and 5.9 months (4.9–7.1) in the bevacizumab arm, comparable to the median OS observed in the overall clinical study[<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071082" role="button" aria-expanded="false" aria-haspopup="true">5</a>]. The number of available SNPs for association with OS was 484,523. Here we present the results of the primary analysis of the SNP vs. OS association in patients of European ancestry (n=294), in both arms combined (<a href="/pmc/articles/PMC3412624/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>).</p><p id="P19">Of the 20 SNPs that showed the most significant association with OS, nine were in annotated genes, one was near a gene, and ten were in intergenic regions (<a href="/pmc/articles/PMC3412624/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). All SNPs in genes were intronic, with the exception of the coding SNP rs763780 in <em>IL17F</em>. The SNP with the highest statistical significance was rs763780 in <em>IL17F</em> (p 2.61×10<sup>−8</sup>), with a MAF of 0.04 (<a href="/pmc/articles/PMC3412624/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Patients who were rs763780 heterozygous had reduced median OS of 3.1 months (2.3–4.3) compared to patients without the variant (no patients were homozygous for the variant), who had a median OS of 6.8 months (5.8–7.3, <a href="/pmc/articles/PMC3412624/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a>). This SNP was also in strong linkage disequilibrium (r<sup>2</sup> 0.955) with another <em>IL17F</em> SNP (rs7771466) having the second highest statistical significance (p 1.66×10<sup>−7</sup>) and a similar effect on OS [3.1 months (2.4–4.3) vs. 6.6 months (5.8–7.2)]. A similar trend was observed in the subset of patients of African ancestry (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material, Figure 3</a>). The associations between the SNPs in <em>IL17F</em> and OS, after adjusting for the stratification factors, treatment arm, and genetic ancestry within Europeans, do not meet the criterion for genome-wide statistical significance (1×10<sup>−7</sup>) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material, Table 1</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3412624/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139958061480896" class="figure"><a href="/pmc/articles/PMC3412624/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3412624_nihms341305f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms341305f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3412624/bin/nihms341305f3.jpg"></a></div><div id="largeobj_idm139958061480896" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3412624/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3412624/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Kaplan-Meier estimate of OS stratified by (A) rs763780 <em>IL17F</em>, (B) rs11644322 <em>WWOX</em>, and (C) rs10883617 <em>BTRC</em> genotypes in patients of European ancestry with both arms combined</strong><p id="P42">For rs763780, A/A, non carriers of rs763780; A/G, heterozygotes. For rs11644322, G/G, non carriers of rs11644322; G/A, heterozygotes; A/A, homozygotes. For rs10883617, A/A, non carriers of rs10883617; A/G, heterozygotes; G/G, homozygotes. The base change is according to the Illumina TOP stranding method for determining strand and allele[<a href="#R33" rid="R33" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">33</a>].</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Twenty most significant SNPs associated with OS in patients of European ancestry in both arms combined</strong><p id="P44">SNP annotation information is according to the SCAN database[<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071076" role="button" aria-expanded="false" aria-haspopup="true">32</a>]using dbSNP version 129. The base change is according to the Illumina TOP stranding method for determining strand and allele[<a href="#R33" rid="R33" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">33</a>]. The rs10883617 SNP islocated &lt;1 Kb 5’ of <em>BTRC</em>. NA, intergenic SNP; HR, hazard ratio; MAF, minor relative allele frequency. The SNP call rate and HWE are shown in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material (Table 3)</a>.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139958056411248" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="center">SNP</th><th rowspan="1" colspan="1" align="center">Chromosome</th><th rowspan="1" colspan="1" align="center">Gene</th><th rowspan="1" colspan="1" align="center">Feature</th><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">5’ flanking<br>gene</th><th rowspan="1" colspan="1" align="center">3’ flanking<br>gene</th><th rowspan="1" colspan="1" align="center">Risk<br>Allele<br>/Control<br>Allele</th><th rowspan="1" colspan="1" align="center">P<br>(unadjusted)</th><th rowspan="1" colspan="1" align="center">HR<br>(95%CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="center">rs763780</td><td rowspan="1" colspan="1" align="center">6</td><td rowspan="1" colspan="1" align="center">IL17F</td><td rowspan="1" colspan="1" align="center">coding<br>nonsynonymous</td><td rowspan="1" colspan="1" align="center">0.039</td><td rowspan="1" colspan="1" align="center">LOC730141</td><td rowspan="1" colspan="1" align="center">SLC25A20P</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">2.61E-08</td><td rowspan="1" colspan="1" align="center">3.3<br>(2.1–5.1)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs7771466</td><td rowspan="1" colspan="1" align="center">6</td><td rowspan="1" colspan="1" align="center">IL17F</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.037</td><td rowspan="1" colspan="1" align="center">LOC730141</td><td rowspan="1" colspan="1" align="center">SLC25A20P</td><td rowspan="1" colspan="1" align="center">A/C</td><td rowspan="1" colspan="1" align="center">1.66E-07</td><td rowspan="1" colspan="1" align="center">3.1<br>(2.0–4.9)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2900174</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">PRB2</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.029</td><td rowspan="1" colspan="1" align="center">PRB1</td><td rowspan="1" colspan="1" align="center">hCG_1655019</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">1.03E-06</td><td rowspan="1" colspan="1" align="center">3.3<br>(2.0–5.5)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs11062040</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">DCP1B</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.498</td><td rowspan="1" colspan="1" align="center">CACNA2D4</td><td rowspan="1" colspan="1" align="center">CACNA1C</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">7.57E-06</td><td rowspan="1" colspan="1" align="center">1.4<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs11644322</td><td rowspan="1" colspan="1" align="center">16</td><td rowspan="1" colspan="1" align="center">WWOX</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.223</td><td rowspan="1" colspan="1" align="center">LOC645947</td><td rowspan="1" colspan="1" align="center">LOC729251</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">1.31E-05</td><td rowspan="1" colspan="1" align="center">1.6<br>(1.3–2.0)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10736526</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">UBASH3B</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.197</td><td rowspan="1" colspan="1" align="center">GLULL3</td><td rowspan="1" colspan="1" align="center">CRTAM</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">1.50E-05</td><td rowspan="1" colspan="1" align="center">1.6<br>(1.3–1.9)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs179619</td><td rowspan="1" colspan="1" align="center">16</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.199</td><td rowspan="1" colspan="1" align="center">LOC729993</td><td rowspan="1" colspan="1" align="center">ERCC4</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">2.07E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.3–1.9)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs306104</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">CAMK4</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.347</td><td rowspan="1" colspan="1" align="center">LOC402287</td><td rowspan="1" colspan="1" align="center">STARD4</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">2.31E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.8)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs3744311</td><td rowspan="1" colspan="1" align="center">17</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.36</td><td rowspan="1" colspan="1" align="center">LOC727973</td><td rowspan="1" colspan="1" align="center">SLC39A11</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">2.53E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10489997</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">BAZ2B</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.405</td><td rowspan="1" colspan="1" align="center">LOC728059</td><td rowspan="1" colspan="1" align="center">LOC643072</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">2.60E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs1910236</td><td rowspan="1" colspan="1" align="center">3</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.471</td><td rowspan="1" colspan="1" align="center">C3orf67</td><td rowspan="1" colspan="1" align="center">hCG_1813818</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">2.71E-05</td><td rowspan="1" colspan="1" align="center">1.4<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs7149097</td><td rowspan="1" colspan="1" align="center">14</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.192</td><td rowspan="1" colspan="1" align="center">CDC42BPB</td><td rowspan="1" colspan="1" align="center">C14orf73</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">3.84E-05</td><td rowspan="1" colspan="1" align="center">1.6<br>(1.3–1.9)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs10883617</td><td rowspan="1" colspan="1" align="center">10</td><td rowspan="1" colspan="1" align="center">BTRC</td><td rowspan="1" colspan="1" align="center">near-gene-5</td><td rowspan="1" colspan="1" align="center">0.35</td><td rowspan="1" colspan="1" align="center">LOC282992</td><td rowspan="1" colspan="1" align="center">BTRC</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">3.94E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.8)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs490332</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.486</td><td rowspan="1" colspan="1" align="center">TSPAN17</td><td rowspan="1" colspan="1" align="center">LOC729378</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">4.32E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs2550731</td><td rowspan="1" colspan="1" align="center">16</td><td rowspan="1" colspan="1" align="center">WWOX</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">0.346</td><td rowspan="1" colspan="1" align="center">LOC645947</td><td rowspan="1" colspan="1" align="center">LOC729251</td><td rowspan="1" colspan="1" align="center">A/C</td><td rowspan="1" colspan="1" align="center">4.44E-05</td><td rowspan="1" colspan="1" align="center">1.4<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs12361312</td><td rowspan="1" colspan="1" align="center">11</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.206</td><td rowspan="1" colspan="1" align="center">LOC441609</td><td rowspan="1" colspan="1" align="center">MS4A2</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">4.62E-05</td><td rowspan="1" colspan="1" align="center">1.5<br>(1.2–1.8)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs4785367</td><td rowspan="1" colspan="1" align="center">16</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.498</td><td rowspan="1" colspan="1" align="center">ZNF423</td><td rowspan="1" colspan="1" align="center">TMEM188</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">5.06E-05</td><td rowspan="1" colspan="1" align="center">1.4<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs814951</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.464</td><td rowspan="1" colspan="1" align="center">FAM5C</td><td rowspan="1" colspan="1" align="center">LOC440704</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">5.38E-05</td><td rowspan="1" colspan="1" align="center">1.4<br>(1.2–1.7)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs7712169</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.024</td><td rowspan="1" colspan="1" align="center">CTNND2</td><td rowspan="1" colspan="1" align="center">LOC391738</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">5.64E-05</td><td rowspan="1" colspan="1" align="center">2.9<br>(1.7–5.0)</td></tr><tr><td rowspan="1" colspan="1" align="center">rs1808458</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">0.036</td><td rowspan="1" colspan="1" align="center">INSIG2</td><td rowspan="1" colspan="1" align="center">LOC645733</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">6.16E-05</td><td rowspan="1" colspan="1" align="center">2.4<br>(1.6–3.8)</td></tr></tbody></table></div><div id="largeobj_idm139958056411248" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3412624/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="P20" class="p p-last">In silico analysis of the putative function of the intronic <em>IL17F</em> rs7771466 variant (in very strong LD with the non-synonymous rs763780) indicates that a) rs7771466 introduces an additional CDX1 transcription factor binding site to one present in the wild-type sequence, and b) rs763780 abolishes an exonic splicing silencer and introduces two exonic splicing enhancers (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Material, Table 2</a>).</p></div><div id="S14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S14title">DISCUSSION</h2><p id="P21" class="p p-first">We interrogated &gt;550,000 heritable variants in patients with advanced pancreatic cancer treated with chemotherapy in CALGB 80303. To our knowledge, this is the first GWAS in a cancer patient population in the context of a randomized, placebo-controlled, clinical trial. This preliminary study generates hypotheses on the role of the <em>IL17F</em> gene in the biology of advanced pancreatic cancer. If replicated, the <em>IL17F</em> SNPs might have prognostic significance.</p><p id="P22"><em>IL17F</em> encodes interleukin-17F, a cytokine with the ability to induce stromal cells to secrete pro-inflammatory cytokines. The most significant SNP in this study is rs763780 in <em>IL17F</em>, a base substitution that alters the histidine to arginine at amino acid 161 (H161R). In vitro functional experiments demonstrated that, in contrast to the wild-type 161H interleukin-17F, the 161R variant form lacks the ability to activate the mitogen-activated protein kinase pathway, thereby restricting cytokine and chemokine production[<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071073" role="button" aria-expanded="false" aria-haspopup="true">15</a>]. Wild-type 161H interleukin-17F has also demonstrated a strong anti-angiogenesis effect by markedly inhibiting the angiogenesis of human endothelial cells and inducing them to produce interleukin-2, TGF-beta, and monocyte chemoattractant protein-1[<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071085" role="button" aria-expanded="false" aria-haspopup="true">16</a>]. A recent study has also shown the anti-angiogenetic and anti-tumor properties of wild-type interleukin-17F in vivo[<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071071" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. With respect to these activities, the variant 161R form of interleukin-17F is a natural antagonist of the anti-angiogenic and pro-inflammatory effects of wild-type 161H interleukin-17F. For example, the 161R variant has been associated with protective effects in Asian patients with inflammatory and autoimmune conditions[<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071069" role="button" aria-expanded="false" aria-haspopup="true">18</a>, <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071058" role="button" aria-expanded="false" aria-haspopup="true">19</a>]. The resulting pro-angiogenic effects of the variant 161R of interleukin-17F could be further magnified by the concomitant increased expression driven by the noncoding rs7771466 <em>IL17F</em> variant. This variant is almost in complete linkage disequilibrium with the nonsynonymous rs763780, and its minor allele seems to increase interleukin-17F expression through splicing enhancement and introduction of an additional CDX1 transcription factor binding site. The putative synergistic effect of these <em>IL17F</em> variants should be verified in experimental models of SNP functionality and angiogenesis.</p><p id="P23">As angiogenesis has been thought to play an important role in the growth and metastatic spread of pancreatic cancer[<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071084" role="button" aria-expanded="false" aria-haspopup="true">20</a>], we hypothesize that the angiogenesis potential of tumors of patients with the variant 161R interleukin-17F is higher than tumors with wild-type 161H interleukin-17F, conferring worse prognosis. However, other mechanisms related to the pro-inflammatory effects of interleukin-17F cannot be excluded.</p><p id="P24">The <em>IL17F</em> rs763780 is the most important candidate SNP discovered by this study, due to 1) the genome-wide significance, 2) its already established molecular function, 3) the mechanistic hypothesis explaining the association with reduced OS, and 4) the suggestion that a trend could be detected in patients of African ancestry, despite the very small sample size. This study proposes that rs763780 in <em>IL17F</em> might have a prognostic effect in advanced pancreatic cancer patients, also because stratification by treatment arm does not seem to negatively affect the association (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Material, Table 1</a>). Because gemcitabine is given in both arms, a true interaction between gemcitabine and <em>IL17F</em> SNPs cannot be tested. Additionally, a review of the clinical characteristics of the patients heterozygous for <em>IL17F</em> rs763780 did not show any obvious difference with respect to the characteristics of the overall population accrued into this study (data not shown).</p><p id="P25">In addition to <em>IL17F</em>, this study proposes additional genes as putatively involved in determining differences in survival among patients with advanced pancreatic cancer. Among the SNPs listed in <a href="/pmc/articles/PMC3412624/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>, rs11644322 in <em>WWOX</em> demonstrated a gene-dosage effect, with median OS in the heterozygous patients (5.3 months, 4.3–6.9) that was intermediate between the other two genotype groups (3.3 months, 2.9–5.7, for the variant homozygotes; 7.1 months, 6.0–8.4, for the wild-type homozygotes; p 1.31×10<sup>−5</sup>; <a href="/pmc/articles/PMC3412624/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>). <em>WWOX</em> codes for the WW domain-containing oxidoreductase, a tumor suppressor in several tumors, including pancreatic cancer[<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071079" role="button" aria-expanded="false" aria-haspopup="true">21</a>]. <em>WWOX</em> SNPs showed the strongest linkage for prostate cancer susceptibility in a recent genome-wide scan[<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071067" role="button" aria-expanded="false" aria-haspopup="true">22</a>]. In multiple myeloma, loss of heterozygosity of 16q23, the location of <em>WWOX</em>, was associated with adverse survival and reduced WWOX expression[<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071072" role="button" aria-expanded="false" aria-haspopup="true">23</a>]. Germline variants from a recent study mapped <em>WWOX</em> as one of the genes associated with clinical staging in lung cancer[<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071066" role="button" aria-expanded="false" aria-haspopup="true">24</a>]. Contrary to the amino acid changing SNP in <em>IL17F</em>, the molecular functions of the SNPs in <em>WWOX</em> are not known at this time. Due to their association with reduced OS, the established tumor suppressor role of <em>WWOX</em>, and their intronic location, we hypothesize that these SNPs might reduce the expression of WWOX, diminishing its tumor suppressor properties, and leading to worse prognosis.</p><p id="P26">A SNP (rs10883617) near <em>BTRC</em> was associated with reduced OS, as homozygote patients had a reduced median OS (3.6 months, 2.7–6.8) compared to heterozygous patients (6.1 months, 4.9–7.3) and patients who were not carriers of this variant (6.9 months, 5.9–8.2; p 3.94×10<sup>−5</sup>, <a href="/pmc/articles/PMC3412624/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>). <em>BTRC</em> (beta-transducin repeat containing) encodes a protein involved in the ubiquitination processes that demonstrated an oncogenic activity in several cancers including pancreatic cancer[<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071075" role="button" aria-expanded="false" aria-haspopup="true">25</a>–<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071059" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. In most tumors, overexpression of BTRC results in the degradation of IKappaB, an inhibitor of the NFkappaB transcription factor, and thus the activation of NFkappaB and the uncontrolled cell proliferation in these tumors. The use of our functional results in lymphoblastoid cell lines treated with gemcitabine indicated that <em>BTRC</em> rs10883617 is associated with increased IC<sub>50</sub> and, hence, resistance to gemcitabine (r 0.21, p 0.008). As inhibiting and silencing NFkappaB have been shown to increase the sensitivity of pancreatic cancer cells to gemcitabine[<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_478713999" role="button" aria-expanded="false" aria-haspopup="true">28</a>, <a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071083" role="button" aria-expanded="false" aria-haspopup="true">29</a>], we hypothesize that <em>BTRC</em> rs10883617 might have a predictive value in pancreatic cancer patients treated with gemcitabine, via a NFkappaB-mediated effect.</p><p id="P27">This study is limited by the large number of multiple comparisons typical of GWAS, increasing the chance of false positive associations. This limitation could be overcome by independent replication of the findings. Replication studies in cancer treatment outcome have intrinsic difficulties, as there may not be an existing trial (to be used for replication) with the same eligibility criteria and drug treatment of the trial used for discovery. In a relatively uncommon disease like pancreatic cancer, the access to a sufficiently powered replication set is particularly challenging. Ideally, validation of our top hits should be conducted in patients treated with gemcitabine and randomized to an experimental treatment, in order to ensure that the populations are comparable. A few published trials[<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071061" role="button" aria-expanded="false" aria-haspopup="true">30</a>, <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_268071065" role="button" aria-expanded="false" aria-haspopup="true">31</a>] where patient DNA has been already collected may be considered for replication, due to similarity of treatment and/or disease, and randomized treatment. Additionally, the MAF of the variants in <em>IL17F</em> is low in Caucasians (0.05 from HapMap), potentially limiting the ability to replicate this association in this population. However, the MAF of the variants in <em>IL17F</em> is higher in Asians (0.13).</p><p id="P28" class="p p-last">The results of this study are preliminary because of the limited sample size and the low MAF of the <em>IL17F</em> SNP. Due to the refractoriness to treatment of advanced pancreatic cancer and the lack of established markers of survival, the dissemination of these findings to the scientific community could facilitate their replication by others, even as we continue to conduct replication and validation studies. The association of <em>IL17F</em> variants with efficacy could be also tested in tumors other than pancreatic cancer. To support this, our data are now available in dbGaP, in accordance with NIH policy.</p></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d35e694"><a href="/pmc/articles/PMC3412624/bin/NIHMS341305-supplement-1.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(182K, doc)</sup></div></div></div><div id="S15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">ACKNOWLEDGEMENT</h2><div class="sec"><p id="P29">The authors would like to acknowledge the helpful suggestions made by Dr. Monica Bertagnolli, Harvard Medical School. This paper was prepared for submission by Michelle Gibeault, University of North Carolina - Chapel Hill.</p><p id="P30"><strong>Grant Support:</strong></p><p id="P31">The research for CALGB 80303 was supported, in part, by grants from the Cancer and Leukemia Group B and the CALGB Statistical Center (CA33601).This study was also supported by K07-CA140390-01, T32 MH200065-06, 5K24-<a id="__tag_783287747" class="tag_hotlink" href="/nuccore/CA113755" ref="/nuccore/CA113755"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA113755","term_id":"34967062","term_text":"CA113755"}}</span>CA113755</a>, CA60138, the U01 GM61393, and the BioBank Japan Project that is funded by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. This study was supported by the NIH Pharmacogenomics Research Network (PGRN) – RIKEN Center for Genomic Medicine (CGM) Strategic Alliance.</p></div></div><div id="idm139958060557408" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139958060557408title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>GWAS</td><td>genome-wide association study</td></tr><tr><td>OS</td><td>overall survival</td></tr><tr><td>SNPs</td><td>single nucleotide polymorphisms</td></tr><tr><td>(CALGB)</td><td>Cancer and Leukemia Group B</td></tr></tbody></table></div></div></div><div id="idm139958056386352" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139958056386352title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"> </p><p id="P36" class="p p-first"><strong>Disclosures:</strong></p><p id="P37" class="p p-last">The authors disclose no conflicts of interest relevant to this manuscript.</p><p></p><p class="fn sec" id="FN2"></p><p id="P38" class="p p-first-last">Preliminary data were presented at the 44<sup>th</sup> Annual Meeting of the American Society of Clinical Oncology (May 29 – June 2, 2009, Orlando, FL, USA).</p><p></p><p class="fn sec" id="FN3"></p><p id="P39" class="p p-first-last">Pancreatic cancer has a very poor prognosis and the lowest survival by stage of any solid tumor. Gemcitabine is the cornerstone of chemotherapy in this disease but has a very modest impact. Novel molecular biomarkers are urgently needed. One approach is to identify novel candidate genes putatively involved in the biology of pancreatic cancer. Through a genome-wide genotyping approach in advanced pancreatic cancer patients treated with chemotherapy, this study identified novel variants in the <em>IL17F</em> gene as associated with survival in advanced pancreatic cancer patients, through a mechanism putatively related to the anti-angiogenetic effects of interleukin-17F. As patients with the variant allele have worse survival, this variant in <em>IL17F</em> could be validated as germline prognosticator of survival of patients with advanced pancreatic cancer. Identification of prognostic markers in advanced pancreatic cancer might improve the management of this disease. According to the results of the GWAS, new biological pathways could be investigated to design novel strategies for therapeutic intervention.</p><p></p></div></div><div id="idm139958098605520" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139958098605520title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2009;<span class="ref-vol">18</span>:1695–1698.</span> [<a href="/pubmed/19505901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Increase+in+incidence+of+colorectal+cancer+among+young+men+and+women+in+the+United+States&amp;author=RL+Siegel&amp;author=A+Jemal&amp;author=EM+Ward&amp;volume=18&amp;publication_year=2009&amp;pages=1695-1698&amp;pmid=19505901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Burris HA, 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. <span><span class="ref-journal">J Clin Oncol. </span>1997;<span class="ref-vol">15</span>:2403–2413.</span> [<a href="/pubmed/9196156" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Improvements+in+survival+and+clinical+benefit+with+gemcitabine+as+first-line+therapy+for+patients+with+advanced+pancreas+cancer:+a+randomized+trial&amp;author=HA+Burris&amp;author=MJ+Moore&amp;author=J+Andersen&amp;author=MR+Green&amp;author=ML+Rothenberg&amp;volume=15&amp;publication_year=1997&amp;pages=2403-2413&amp;pmid=9196156&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Pliarchopoulou K, Pectasides D. Pancreatic cancer: current and future treatment strategies. <span><span class="ref-journal">Cancer Treat Rev. </span>2009;<span class="ref-vol">35</span>:431–436.</span> [<a href="/pubmed/19328630" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Treat+Rev&amp;title=Pancreatic+cancer:+current+and+future+treatment+strategies&amp;author=K+Pliarchopoulou&amp;author=D+Pectasides&amp;volume=35&amp;publication_year=2009&amp;pages=431-436&amp;pmid=19328630&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Hartman M, Loy EY, Ku CS, Chia KS. Molecular epidemiology and its current clinical use in cancer management. <span><span class="ref-journal">Lancet Oncol. </span><span class="ref-vol">11</span>:383–390.</span> [<a href="/pubmed/20359664" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Molecular+epidemiology+and+its+current+clinical+use+in+cancer+management&amp;author=M+Hartman&amp;author=EY+Loy&amp;author=CS+Ku&amp;author=KS+Chia&amp;volume=11&amp;pages=383-390&amp;pmid=20359664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, et al.  Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303) <span><span class="ref-journal">J Clin Oncol. </span><span class="ref-vol">28</span>:3617–3622.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2917317/">PMC free article</a>]</span> [<a href="/pubmed/20606091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Gemcitabine+plus+bevacizumab+compared+with+gemcitabine+plus+placebo+in+patients+with+advanced+pancreatic+cancer:+phase+III+trial+of+the+Cancer+and+Leukemia+Group+B+(CALGB+80303)&amp;author=HL+Kindler&amp;author=D+Niedzwiecki&amp;author=D+Hollis&amp;author=S+Sutherland&amp;author=D+Schrag&amp;volume=28&amp;pages=3617-3622&amp;pmid=20606091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Innocenti F, Cox NJ, Dolan ME. The use of genomic information to optimize cancer chemotherapy. <span><span class="ref-journal">Semin Oncol. </span><span class="ref-vol">38</span>:186–195.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3076508/">PMC free article</a>]</span> [<a href="/pubmed/21421109" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Oncol&amp;title=The+use+of+genomic+information+to+optimize+cancer+chemotherapy&amp;author=F+Innocenti&amp;author=NJ+Cox&amp;author=ME+Dolan&amp;volume=38&amp;pages=186-195&amp;pmid=21421109&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, et al.  Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303) <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>:3617–3622.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2917317/">PMC free article</a>]</span> [<a href="/pubmed/20606091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Gemcitabine+plus+bevacizumab+compared+with+gemcitabine+plus+placebo+in+patients+with+advanced+pancreatic+cancer:+phase+III+trial+of+the+Cancer+and+Leukemia+Group+B+(CALGB+80303)&amp;author=HL+Kindler&amp;author=D+Niedzwiecki&amp;author=D+Hollis&amp;author=S+Sutherland&amp;author=D+Schrag&amp;volume=28&amp;publication_year=2010&amp;pages=3617-3622&amp;pmid=20606091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. <span><span class="ref-journal">J Natl Cancer Inst. </span>2000;<span class="ref-vol">92</span>:205–216.</span> [<a href="/pubmed/10655437" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=New+guidelines+to+evaluate+the+response+to+treatment+in+solid+tumors.+European+Organization+for+Research+and+Treatment+of+Cancer,+National+Cancer+Institute+of+the+United+States,+National+Cancer+Institute+of+Canada&amp;author=P+Therasse&amp;author=SG+Arbuck&amp;author=EA+Eisenhauer&amp;author=J+Wanders&amp;author=RS+Kaplan&amp;volume=92&amp;publication_year=2000&amp;pages=205-216&amp;pmid=10655437&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Iida A, Saito S, Sekine A, Takahashi A, Kamatani N, Nakamura Y. Japanese single nucleotide polymorphism database for 267 possible drug-related genes. <span><span class="ref-journal">Cancer Sci. </span>2006;<span class="ref-vol">97</span>:16–24.</span> [<a href="/pubmed/16367916" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Japanese+single+nucleotide+polymorphism+database+for+267+possible+drug-related+genes&amp;author=A+Iida&amp;author=S+Saito&amp;author=A+Sekine&amp;author=A+Takahashi&amp;author=N+Kamatani&amp;volume=97&amp;publication_year=2006&amp;pages=16-24&amp;pmid=16367916&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. <span><span class="ref-journal">Nucleic Acids Res. </span>2006;<span class="ref-vol">34</span>:W635–W641.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1538865/">PMC free article</a>]</span> [<a href="/pubmed/16845089" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=FASTSNP:+an+always+up-to-date+and+extendable+service+for+SNP+function+analysis+and+prioritization&amp;author=HY+Yuan&amp;author=JJ+Chiou&amp;author=WH+Tseng&amp;author=CH+Liu&amp;author=CK+Liu&amp;volume=34&amp;publication_year=2006&amp;pages=W635-W641&amp;pmid=16845089&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Li L, Fridley BL, Kalari K, Jenkins G, Batzler A, Weinshilboum RM, et al.  Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e7765.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2770319/">PMC free article</a>]</span> [<a href="/pubmed/19898621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Gemcitabine+and+arabinosylcytosin+pharmacogenomics:+genome-wide+association+and+drug+response+biomarkers&amp;author=L+Li&amp;author=BL+Fridley&amp;author=K+Kalari&amp;author=G+Jenkins&amp;author=A+Batzler&amp;volume=4&amp;publication_year=2009&amp;pages=e7765&amp;pmid=19898621&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">R Development Core Team. A language and environment for statistical computing [Internet] <span></span> [updated 2006 April 21; cited 2010 July 7]. Available from:  <a href="http://www.R-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.R-project.org</a>.</span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Therneau TM, Grambsch PM.  <span class="ref-journal">Modeling survival data: extending the Cox model.</span> New York: Springer; 2000.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Modeling+survival+data:+extending+the+Cox+model&amp;author=TM+Therneau&amp;author=PM+Grambsch&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, et al.  IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2006;<span class="ref-vol">117</span>:795–801.</span> [<a href="/pubmed/16630936" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=IL-17F+sequence+variant+(His161Arg)+is+associated+with+protection+against+asthma+and+antagonizes+wild-type+IL-17F+activity&amp;author=M+Kawaguchi&amp;author=D+Takahashi&amp;author=N+Hizawa&amp;author=S+Suzuki&amp;author=S+Matsukura&amp;volume=117&amp;publication_year=2006&amp;pages=795-801&amp;pmid=16630936&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, et al.  Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. <span><span class="ref-journal">J Immunol. </span>2001;<span class="ref-vol">167</span>:4137–4140.</span> [<a href="/pubmed/11591732" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Cutting+edge:+IL-17F,+a+novel+cytokine+selectively+expressed+in+activated+T+cells+and+monocytes,+regulates+angiogenesis+and+endothelial+cell+cytokine+production&amp;author=T+Starnes&amp;author=MJ+Robertson&amp;author=G+Sledge&amp;author=S+Kelich&amp;author=H+Nakshatri&amp;volume=167&amp;publication_year=2001&amp;pages=4137-4140&amp;pmid=11591732&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Xie Y, Sheng W, Xiang J, Ye Z, Yang J. Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis. <span><span class="ref-journal">Cancer Invest. </span><span class="ref-vol">28</span>:598–607.</span> [<a href="/pubmed/20210523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Invest&amp;title=Interleukin-17F+suppresses+hepatocarcinoma+cell+growth+via+inhibition+of+tumor+angiogenesis&amp;author=Y+Xie&amp;author=W+Sheng&amp;author=J+Xiang&amp;author=Z+Ye&amp;author=J+Yang&amp;volume=28&amp;pages=598-607&amp;pmid=20210523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al.  Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia. <span><span class="ref-journal">Int J Mol Med. </span>2007;<span class="ref-vol">20</span>:717–723.</span> [<a href="/pubmed/17912466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Med&amp;title=Genetic+polymorphisms+of+molecules+associated+with+inflammation+and+immune+response+in+Japanese+subjects+with+functional+dyspepsia&amp;author=T+Arisawa&amp;author=T+Tahara&amp;author=T+Shibata&amp;author=M+Nagasaka&amp;author=M+Nakamura&amp;volume=20&amp;publication_year=2007&amp;pages=717-723&amp;pmid=17912466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al.  The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. <span><span class="ref-journal">J Clin Immunol. </span>2008;<span class="ref-vol">28</span>:44–49.</span> [<a href="/pubmed/17828618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Immunol&amp;title=The+influence+of+polymorphisms+of+interleukin-17A+and+interleukin-17F+genes+on+the+susceptibility+to+ulcerative+colitis&amp;author=T+Arisawa&amp;author=T+Tahara&amp;author=T+Shibata&amp;author=M+Nagasaka&amp;author=M+Nakamura&amp;volume=28&amp;publication_year=2008&amp;pages=44-49&amp;pmid=17828618&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Korc M. Pathways for aberrant angiogenesis in pancreatic cancer. <span><span class="ref-journal">Mol Cancer. </span>2003;<span class="ref-vol">2</span>:8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC149422/">PMC free article</a>]</span> [<a href="/pubmed/12556241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer&amp;title=Pathways+for+aberrant+angiogenesis+in+pancreatic+cancer&amp;author=M+Korc&amp;volume=2&amp;publication_year=2003&amp;pages=8&amp;pmid=12556241&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Del Mare S, Salah Z, Aqeilan RI. WWOX: its genomics, partners, and functions. <span><span class="ref-journal">J Cell Biochem. </span>2009;<span class="ref-vol">108</span>:737–745.</span> [<a href="/pubmed/19708029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem&amp;title=WWOX:+its+genomics,+partners,+and+functions&amp;author=S+Del+Mare&amp;author=Z+Salah&amp;author=RI+Aqeilan&amp;volume=108&amp;publication_year=2009&amp;pages=737-745&amp;pmid=19708029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, et al.  Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. <span><span class="ref-journal">Prostate. </span>2009;<span class="ref-vol">69</span>:385–391.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2712837/">PMC free article</a>]</span> [<a href="/pubmed/19035517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Genome-wide+linkage+scan+for+prostate+cancer+susceptibility+from+the+University+of+Michigan+Prostate+Cancer+Genetics+Project:+suggestive+evidence+for+linkage+at+16q23&amp;author=EM+Lange&amp;author=JL+Beebe-Dimmer&amp;author=AM+Ray&amp;author=KA+Zuhlke&amp;author=J+Ellis&amp;volume=69&amp;publication_year=2009&amp;pages=385-391&amp;pmid=19035517&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, et al.  Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>:3291–3300.</span> [<a href="/pubmed/17609426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Gene+mapping+and+expression+analysis+of+16q+loss+of+heterozygosity+identifies+WWOX+and+CYLD+as+being+important+in+determining+clinical+outcome+in+multiple+myeloma&amp;author=MW+Jenner&amp;author=PE+Leone&amp;author=BA+Walker&amp;author=FM+Ross&amp;author=DC+Johnson&amp;volume=110&amp;publication_year=2007&amp;pages=3291-3300&amp;pmid=17609426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Frullanti E, Galvan A, Falvella FS, Manenti G, Colombo F, Vannelli A, et al.  Multiple genetic Loci modulate lung adenocarcinoma clinical staging. <span><span class="ref-journal">Clin Cancer Res. </span><span class="ref-vol">17</span>:2410–2416.</span> [<a href="/pubmed/21242121" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Multiple+genetic+Loci+modulate+lung+adenocarcinoma+clinical+staging&amp;author=E+Frullanti&amp;author=A+Galvan&amp;author=FS+Falvella&amp;author=G+Manenti&amp;author=F+Colombo&amp;volume=17&amp;pages=2410-2416&amp;pmid=21242121&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Gerstein AV, Almeida TA, Zhao G, Chess E, Shih Ie M, Buhler K, et al.  APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2002;<span class="ref-vol">34</span>:9–16.</span> [<a href="/pubmed/11921277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Chromosomes+Cancer&amp;title=APC/CTNNB1+(beta-catenin)+pathway+alterations+in+human+prostate+cancers&amp;author=AV+Gerstein&amp;author=TA+Almeida&amp;author=G+Zhao&amp;author=E+Chess&amp;author=M+Shih+Ie&amp;volume=34&amp;publication_year=2002&amp;pages=9-16&amp;pmid=11921277&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al.  The genomic landscapes of human breast and colorectal cancers. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">318</span>:1108–1113.</span> [<a href="/pubmed/17932254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+genomic+landscapes+of+human+breast+and+colorectal+cancers&amp;author=LD+Wood&amp;author=DW+Parsons&amp;author=S+Jones&amp;author=J+Lin&amp;author=T+Sjoblom&amp;volume=318&amp;publication_year=2007&amp;pages=1108-1113&amp;pmid=17932254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Muerkoster S, Arlt A, Sipos B, Witt M, Grossmann M, Kloppel G, et al.  Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells. <span><span class="ref-journal">Cancer Res. </span>2005;<span class="ref-vol">65</span>:1316–1324.</span> [<a href="/pubmed/15735017" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Increased+expression+of+the+E3-ubiquitin+ligase+receptor+subunit+betaTRCP1+relates+to+constitutive+nuclear+factor-kappaB+activation+and+chemoresistance+in+pancreatic+carcinoma+cells&amp;author=S+Muerkoster&amp;author=A+Arlt&amp;author=B+Sipos&amp;author=M+Witt&amp;author=M+Grossmann&amp;volume=65&amp;publication_year=2005&amp;pages=1316-1324&amp;pmid=15735017&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Pan X, Arumugam T, Yamamoto T, Levin PA, Ramachandran V, Ji B, et al.  Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. <span><span class="ref-journal">Clin Cancer Res. </span>2008;<span class="ref-vol">14</span>:8143–8151.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4403242/">PMC free article</a>]</span> [<a href="/pubmed/19088029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Nuclear+factor-kappaB+p65/relA+silencing+induces+apoptosis+and+increases+gemcitabine+effectiveness+in+a+subset+of+pancreatic+cancer+cells&amp;author=X+Pan&amp;author=T+Arumugam&amp;author=T+Yamamoto&amp;author=PA+Levin&amp;author=V+Ramachandran&amp;volume=14&amp;publication_year=2008&amp;pages=8143-8151&amp;pmid=19088029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Guo X, Xu B, Pandey S, Goessl E, Brown J, Armesilla AL, et al.  Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. <span><span class="ref-journal">Cancer Lett. </span><span class="ref-vol">290</span>:104–113.</span> [<a href="/pubmed/19782464" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Disulfiram/copper+complex+inhibiting+NFkappaB+activity+and+potentiating+cytotoxic+effect+of+gemcitabine+on+colon+and+breast+cancer+cell+lines&amp;author=X+Guo&amp;author=B+Xu&amp;author=S+Pandey&amp;author=E+Goessl&amp;author=J+Brown&amp;volume=290&amp;pages=104-113&amp;pmid=19782464&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, et al.  Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>:2231–2237.</span> [<a href="/pubmed/19307500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Phase+III+trial+of+bevacizumab+in+combination+with+gemcitabine+and+erlotinib+in+patients+with+metastatic+pancreatic+cancer&amp;author=E+Van+Cutsem&amp;author=WL+Vervenne&amp;author=J+Bennouna&amp;author=Y+Humblet&amp;author=S+Gill&amp;volume=27&amp;publication_year=2009&amp;pages=2231-2237&amp;pmid=19307500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, et al.  Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:4672–4678.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2653128/">PMC free article</a>]</span> [<a href="/pubmed/18824714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Association+of+vascular+endothelial+growth+factor+and+vascular+endothelial+growth+factor+receptor-2+genetic+polymorphisms+with+outcome+in+a+trial+of+paclitaxel+compared+with+paclitaxel+plus+bevacizumab+in+advanced+breast+cancer:+ECOG+2100&amp;author=BP+Schneider&amp;author=M+Wang&amp;author=M+Radovich&amp;author=GW+Sledge&amp;author=S+Badve&amp;volume=26&amp;publication_year=2008&amp;pages=4672-4678&amp;pmid=18824714&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al.  SCAN: SNP and copy number annotation. <span><span class="ref-journal">Bioinformatics. </span><span class="ref-vol">26</span>:259–262.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2852202/">PMC free article</a>]</span> [<a href="/pubmed/19933162" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=SCAN:+SNP+and+copy+number+annotation&amp;author=ER+Gamazon&amp;author=W+Zhang&amp;author=A+Konkashbaev&amp;author=S+Duan&amp;author=EO+Kistner&amp;volume=26&amp;pages=259-262&amp;pmid=19933162&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Illumina. "TOP/BOT" strand and "A/B" allele: A guide to Illumina's method for determining Strand and Allele for the GoldenGate and Infinium Assays [Internet] <span></span> [updated 2006 June 27; cited 2010 December 23]. Available from:  <a href="http://www.illumina.com/documents/products/technotes/technote_topbot.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.illumina.com/documents/products/technotes/technote_topbot.pdf</a>.</span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139958060331392title">Abstract</a></li><li><a href="#S5title">INTRODUCTION</a></li><li><a href="#S6title">PATIENTS AND METHODS</a></li><li><a href="#S13title">RESULTS</a></li><li><a href="#S14title">DISCUSSION</a></li><li><a href="#SMtitle">Supplementary Material</a></li><li><a href="#S15title">ACKNOWLEDGEMENT</a></li><li><a href="#idm139958060557408title">Abbreviations</a></li><li><a href="#idm139958056386352title">Footnotes</a></li><li><a href="#idm139958098605520title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3412624/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3412624/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3412624/pdf/nihms341305.pdf">PDF (717K)</a></li> | <li><a href="#" data-citationid="PMC3412624" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3412624%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3412624%2F&amp;text=A%20genome-wide%20association%20study%20of%20overall%20survival%20in%20pancreatic%20cancer%20patients%20treated%20with%20gemcitabine%20in%20CALGB%2080303" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3412624%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22142827" data-aiid="3412624" data-aid="3412624" data-iid="212764" data-domainid="319" data-domain="nihpa" data-accid="PMC3412624" data-md5="63478a4ebf511ed9d212926074f4307e">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="3412624" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/26857392" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.</a><span class="source">[J Natl Cancer Inst. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schirmer MA, Lüske CM, Roppel S, Schaudinn A, Zimmer C, Pflüger R, Haubrock M, Rapp J, Güngör C, Bockhorn M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Natl Cancer Inst. 2016 May; 108(5). Epub 2016 Feb 8.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/30107003" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.</a><span class="source">[PLoS One. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS One. 2018; 13(8):e0202272. Epub 2018 Aug 14.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25638248" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.</a><span class="source">[J Natl Cancer Inst. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldstein D, El-Maraghi RH, Hammel P, Heinemann V, Kunzmann V, Sastre J, Scheithauer W, Siena S, Tabernero J, Teixeira L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Natl Cancer Inst. 2015 Feb; 107(2). Epub 2015 Jan 31.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/12449037" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Gemcitabine and pancreatic cancer].</a><span class="source">[Bull Cancer. 2002]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Prost P, Ychou M, Azria D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Bull Cancer. 2002 Aug; 89 Spec No:S91-5. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/15679252" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Chemoradiation for pancreatic adenocarcinoma].</a><span class="source">[Cancer Radiother. 2004]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer Radiother. 2004 Nov; 8 Suppl 1:S80-7. </em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22142827&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22142827&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed ui-ncbitoggler" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="false" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" style="display: none;" id="ui-portlet_content-12" aria-hidden="true">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6670020/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA</a><span class="source">[Molecular Oncology. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lee J, Park SS, Lee YK, Norton JA, Jeffrey SS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Molecular Oncology. 2019 Jul 30; 13(8): 1623-1650</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6636684/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">An Initial Genetic Analysis of Gemcitabine-Induced High-Grade Neutropenia in Pancreatic Cancer Patients in CALGB 80303 (Alliance)</a><span class="source">[Pharmacogenetics and genomics....]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Innocenti F, Jiang C, Sibley AB, Denning S, Etheridge AS, Watson D, Niedzwiecki D, Hatch AJ, Hurwitz HI, Nixon AB, Furukawa Y, Kubo M, Crona DJ, Kindler HL, McLeod HL, Ratain MJ, Owzar K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pharmacogenetics and genomics. 2019 Aug; 29(6): 123-131</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6583393/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants</a><span class="source">[JAMA Surgery. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dimitrakopoulos C, Vrugt B, Flury R, Schraml P, Knippschild U, Wild P, Hoerstrup S, Henne-Bruns D, Wuerl P, Graf R, Breitenstein S, Bond G, Beerenwinkel N, Grochola LF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">JAMA Surgery. 2019 Apr 3; 154(6): e190484</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6567636/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studies</a><span class="source">[BMC Bioinformatics. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin J, Sibley A, Shterev I, Nixon A, Innocenti F, Chan C, Owzar K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Bioinformatics. 2019 Jun 13; 20: 333</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6303260/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Exploring predictive biomarkers from clinical genome-wide association studies via multidimensional hierarchical mixture models</a><span class="source">[European Journal of Human Gene...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Otani T, Noma H, Sugasawa S, Kuchiba A, Goto A, Yamaji T, Kochi Y, Iwasaki M, Matsui S, Tsunoda T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">European Journal of Human Genetics. 2018 Sep 10; 27(1): 140-149</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed ui-ncbitoggler" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-18" role="button" aria-expanded="false" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" style="display: none;" id="ui-portlet_content-18" aria-hidden="true"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3412624" ref="reftype=Compound&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=3412624" ref="reftype=Gene&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene_nucleotide&amp;IdsFromResult=3412624" ref="reftype=Gene%20(nucleotide)&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene (nucleotide)</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene (nucleotide)<div class="brieflinkpopdesc">Records in Gene identified from shared sequence links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=3412624" ref="reftype=GEO%20Profiles&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=3412624" ref="reftype=HomoloGene&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|HomoloGene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HomoloGene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3412624" ref="reftype=MedGen&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=nuccore&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nuccore&amp;IdsFromResult=3412624" ref="reftype=Nucleotide&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Nucleotide&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Nucleotide</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Nucleotide<div class="brieflinkpopdesc">Published Nucleotide sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=protein&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_protein&amp;IdsFromResult=3412624" ref="reftype=Protein&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Protein&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Protein</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-26" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Protein<div class="brieflinkpopdesc">Published protein sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/22142827/" ref="reftype=PubMed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-27" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=3412624" ref="reftype=SNP&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-28" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3412624" ref="reftype=Substance&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-29" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3412624" ref="reftype=Taxonomy&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-30" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-31" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-31" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd53c7ddde0893a8b8ff4e1">A genome-wide association study of overall survival in pancreatic cancer patient...</a><div class="ralinkpop offscreen_noflow">A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2012 Jan 15; 18(2)577</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd53c4ddd2142621d5173c2">New gene functions in megakaryopoiesis and platelet formation</a><div class="ralinkpop offscreen_noflow">New gene functions in megakaryopoiesis and platelet formation<div class="brieflinkpopdesc">NIHPA Author Manuscripts. ; 480(7376)201</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd53c1075f66d018f645df6">Replication of loci influencing ages at menarche and menopause in Hispanic women...</a><div class="ralinkpop offscreen_noflow">Replication of loci influencing ages at menarche and menopause in Hispanic women: the Women's Health Initiative SHARe Study<div class="brieflinkpopdesc">Human Molecular Genetics. 2012 Mar 15; 21(6)1419</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd53bd775f66d018f5b5101">New variants at 10q26 and 15q21 are associated with aggressive prostate cancer i...</a><div class="ralinkpop offscreen_noflow">New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort<div class="brieflinkpopdesc">Cancer Biology &amp;#x0026; Therapy. 2011 Dec 1; 12(11)997</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd53bb975f66d018f561adb">Identification of Six Loci Associated With Pelvic Organ Prolapse Using Genome-Wi...</a><div class="ralinkpop offscreen_noflow">Identification of Six Loci Associated With Pelvic Organ Prolapse Using Genome-Wide Association Analysis<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Dec; 118(6)1345</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1470px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="R1">
<a href="/pubmed/19505901/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Increase in incidence of colorectal cancer among young men and women in the United States.</a><span class="one_line_source">[Cancer Epidemiol Biomarkers Prev.  2009]</span><div class="alt-note">
<div class="authors">Siegel RL, Jemal A, Ward EM</div>
<div class="citation">Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1695-8.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="/pubmed/9196156/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.</a><span class="one_line_source">[J Clin Oncol.  1997]</span><div class="alt-note">
<div class="authors">Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD</div>
<div class="citation">J Clin Oncol. 1997 Jun; 15(6):2403-13.</div>
</div>
</li>
<li class="two_line" reference_id="R3">
<a href="/pubmed/19328630/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pancreatic cancer: current and future treatment strategies.</a><span class="one_line_source">[Cancer Treat Rev.  2009]</span><div class="alt-note">
<div class="authors">Pliarchopoulou K, Pectasides D</div>
<div class="citation">Cancer Treat Rev. 2009 Aug; 35(5):431-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P6" name="crb--P6" rid="P6" style="position: absolute; visibility: visible; width: 370px; top: 1613px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="R4">
<a href="/pubmed/20359664/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Molecular epidemiology and its current clinical use in cancer management.</a><span class="one_line_source">[Lancet Oncol.  2010]</span><div class="alt-note">
<div class="authors">Hartman M, Loy EY, Ku CS, Chia KS</div>
<div class="citation">Lancet Oncol. 2010 Apr; 11(4):383-90.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).</a><span class="one_line_source">[J Clin Oncol.  2010]</span><div class="alt-note">
<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div>
<div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P7" name="crb--P7" rid="P7" style="position: absolute; visibility: visible; width: 370px; top: 1756px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="two_line" reference_id="R6">
<a href="/pubmed/21421109/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The use of genomic information to optimize cancer chemotherapy.</a><span class="one_line_source">[Semin Oncol.  2011]</span><div class="alt-note">
<div class="authors">Innocenti F, Cox NJ, Dolan ME</div>
<div class="citation">Semin Oncol. 2011 Apr; 38(2):186-95.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P8" name="crb--P8" rid="P8" style="position: absolute; visibility: visible; width: 370px; top: 2003px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul><li class="two_line" reference_id="R7">
<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).</a><span class="one_line_source">[J Clin Oncol.  2010]</span><div class="alt-note">
<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div>
<div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P9" name="crb--P9" rid="P9" style="position: absolute; visibility: visible; width: 370px; top: 2191px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul><li class="two_line" reference_id="R8">
<a href="/pubmed/10655437/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.</a><span class="one_line_source">[J Natl Cancer Inst.  2000]</span><div class="alt-note">
<div class="authors">Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG</div>
<div class="citation">J Natl Cancer Inst. 2000 Feb 2; 92(3):205-16.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P11" name="crb--P11" rid="P11" style="position: absolute; visibility: visible; width: 370px; top: 3183px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul><li class="two_line" reference_id="R5">
<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).</a><span class="one_line_source">[J Clin Oncol.  2010]</span><div class="alt-note">
<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div>
<div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P12" name="crb--P12" rid="P12" style="position: absolute; visibility: visible; width: 370px; top: 3393px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul><li class="two_line" reference_id="R9">
<a href="/pubmed/16367916/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Japanese single nucleotide polymorphism database for 267 possible drug-related genes.</a><span class="one_line_source">[Cancer Sci.  2006]</span><div class="alt-note">
<div class="authors">Iida A, Saito S, Sekine A, Takahashi A, Kamatani N, Nakamura Y</div>
<div class="citation">Cancer Sci. 2006 Jan; 97(1):16-24.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P15" name="crb--P15" rid="P15" style="position: absolute; visibility: visible; width: 370px; top: 4615px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul><li class="two_line" reference_id="R10">
<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Principal components analysis corrects for stratification in genome-wide association studies.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div>
<div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 4864px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="R11">
<a href="/pubmed/16845089/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.</a><span class="one_line_source">[Nucleic Acids Res.  2006]</span><div class="alt-note">
<div class="authors">Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN</div>
<div class="citation">Nucleic Acids Res. 2006 Jul 1; 34(Web Server issue):W635-41.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="/pubmed/19898621/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.</a><span class="one_line_source">[PLoS One.  2009]</span><div class="alt-note">
<div class="authors">Li L, Fridley BL, Kalari K, Jenkins G, Batzler A, Weinshilboum RM, Wang L</div>
<div class="citation">PLoS One. 2009 Nov 9; 4(11):e7765.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P18" name="crb--P18" rid="P18" style="position: absolute; visibility: visible; width: 370px; top: 5731px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul><li class="two_line" reference_id="R5">
<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).</a><span class="one_line_source">[J Clin Oncol.  2010]</span><div class="alt-note">
<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div>
<div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P22" name="crb--P22" rid="P22" style="position: absolute; visibility: visible; width: 370px; top: 7551px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul>
<li class="two_line" reference_id="R15">
<a href="/pubmed/16630936/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity.</a><span class="one_line_source">[J Allergy Clin Immunol.  2006]</span><div class="alt-note">
<div class="authors">Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, Maeda Y, Fukui Y, Konno S, Huang SK, Nishimura M, Adachi M</div>
<div class="citation">J Allergy Clin Immunol. 2006 Apr; 117(4):795-801.</div>
</div>
</li>
<li class="two_line" reference_id="R16">
<a href="/pubmed/11591732/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production.</a><span class="one_line_source">[J Immunol.  2001]</span><div class="alt-note">
<div class="authors">Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R</div>
<div class="citation">J Immunol. 2001 Oct 15; 167(8):4137-40.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="/pubmed/20210523/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis.</a><span class="one_line_source">[Cancer Invest.  2010]</span><div class="alt-note">
<div class="authors">Xie Y, Sheng W, Xiang J, Ye Z, Yang J</div>
<div class="citation">Cancer Invest. 2010 Jul; 28(6):598-607.</div>
</div>
</li>
<li class="two_line" reference_id="R18">
<a href="/pubmed/17912466/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia.</a><span class="one_line_source">[Int J Mol Med.  2007]</span><div class="alt-note">
<div class="authors">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H</div>
<div class="citation">Int J Mol Med. 2007 Nov; 20(5):717-23.</div>
</div>
</li>
<li class="two_line" reference_id="R19">
<a href="/pubmed/17828618/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.</a><span class="one_line_source">[J Clin Immunol.  2008]</span><div class="alt-note">
<div class="authors">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H</div>
<div class="citation">J Clin Immunol. 2008 Jan; 28(1):44-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P23" name="crb--P23" rid="P23" style="position: absolute; visibility: visible; width: 370px; top: 7958px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul><li class="two_line" reference_id="R20">
<a href="/pubmed/12556241/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pathways for aberrant angiogenesis in pancreatic cancer.</a><span class="one_line_source">[Mol Cancer.  2003]</span><div class="alt-note">
<div class="authors">Korc M</div>
<div class="citation">Mol Cancer. 2003 Jan 7; 2():8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 8288px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul>
<li class="two_line" reference_id="R21">
<a href="/pubmed/19708029/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> WWOX: its genomics, partners, and functions.</a><span class="one_line_source">[J Cell Biochem.  2009]</span><div class="alt-note">
<div class="authors">Del Mare S, Salah Z, Aqeilan RI</div>
<div class="citation">J Cell Biochem. 2009 Nov 1; 108(4):737-45.</div>
</div>
</li>
<li class="two_line" reference_id="R22">
<a href="/pubmed/19035517/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.</a><span class="one_line_source">[Prostate.  2009]</span><div class="alt-note">
<div class="authors">Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA</div>
<div class="citation">Prostate. 2009 Mar 1; 69(4):385-91.</div>
</div>
</li>
<li class="two_line" reference_id="R23">
<a href="/pubmed/17609426/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.</a><span class="one_line_source">[Blood.  2007]</span><div class="alt-note">
<div class="authors">Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, Chiecchio L, Dachs Cabanas E, Dagrada GP, Nightingale M, Protheroe RK, Stockley D, Else M, Dickens NJ, Cross NC, Davies FE, Morgan GJ</div>
<div class="citation">Blood. 2007 Nov 1; 110(9):3291-300.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="/pubmed/21242121/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multiple genetic loci modulate lung adenocarcinoma clinical staging.</a><span class="one_line_source">[Clin Cancer Res.  2011]</span><div class="alt-note">
<div class="authors">Frullanti E, Galvan A, Falvella FS, Manenti G, Colombo F, Vannelli A, Incarbone M, Alloisio M, Nosotti M, Santambrogio L, Gonzalez-Neira A, Pastorino U, Dragani TA</div>
<div class="citation">Clin Cancer Res. 2011 Apr 15; 17(8):2410-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P26" name="crb--P26" rid="P26" style="position: absolute; visibility: visible; width: 370px; top: 8608px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul>
<li class="two_line" reference_id="R25">
<a href="/pubmed/11921277/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers.</a><span class="one_line_source">[Genes Chromosomes Cancer.  2002]</span><div class="alt-note">
<div class="authors">Gerstein AV, Almeida TA, Zhao G, Chess E, Shih IeM, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N</div>
<div class="citation">Genes Chromosomes Cancer. 2002 May; 34(1):9-16.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="/pubmed/15735017/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.</a><span class="one_line_source">[Cancer Res.  2005]</span><div class="alt-note">
<div class="authors">Müerköster S, Arlt A, Sipos B, Witt M, Grossmann M, Klöppel G, Kalthoff H, Fölsch UR, Schäfer H</div>
<div class="citation">Cancer Res. 2005 Feb 15; 65(4):1316-24.</div>
</div>
</li>
<li class="two_line" reference_id="R28">
<a href="/pubmed/19088029/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Pan X, Arumugam T, Yamamoto T, Levin PA, Ramachandran V, Ji B, Lopez-Berestein G, Vivas-Mejia PE, Sood AK, McConkey DJ, Logsdon CD</div>
<div class="citation">Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="/pubmed/19782464/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines.</a><span class="one_line_source">[Cancer Lett.  2010]</span><div class="alt-note">
<div class="authors">Guo X, Xu B, Pandey S, Goessl E, Brown J, Armesilla AL, Darling JL, Wang W</div>
<div class="citation">Cancer Lett. 2010 Apr 1; 290(1):104-13.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 8884px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul>
<li class="two_line" reference_id="R30">
<a href="/pubmed/19307500/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.</a><span class="one_line_source">[J Clin Oncol.  2009]</span><div class="alt-note">
<div class="authors">Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ</div>
<div class="citation">J Clin Oncol. 2009 May 1; 27(13):2231-7.</div>
</div>
</li>
<li class="two_line" reference_id="R31">
<a href="/pubmed/18824714/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.</a><span class="one_line_source">[J Clin Oncol.  2008]</span><div class="alt-note">
<div class="authors">Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD, ECOG 2100.</div>
<div class="citation">J Clin Oncol. 2008 Oct 1; 26(28):4672-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P44" name="crb--P44" rid="P44" style="position: absolute; visibility: visible; width: 370px; top: 6568px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-47"><ul><li class="two_line" reference_id="R32">
<a href="/pubmed/19933162/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">SCAN: SNP and copy number annotation.</a><span class="one_line_source">[Bioinformatics.  2010]</span><div class="alt-note">
<div class="authors">Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, Dolan ME, Cox NJ</div>
<div class="citation">Bioinformatics. 2010 Jan 15; 26(2):259-62.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Increase in incidence of colorectal cancer among young men and women in the United States.<div class="authors">Siegel RL, Jemal A, Ward EM</div><div class="citation">Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1695-8.</div><p>[<a href="/pubmed/19505901/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R1">Ref list</a>]</p></div><div id="body-link-popper-R2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.<div class="authors">Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD</div><div class="citation">J Clin Oncol. 1997 Jun; 15(6):2403-13.</div><p>[<a href="/pubmed/9196156/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R2">Ref list</a>]</p></div><div id="body-link-popper-R3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pancreatic cancer: current and future treatment strategies.<div class="authors">Pliarchopoulou K, Pectasides D</div><div class="citation">Cancer Treat Rev. 2009 Aug; 35(5):431-6.</div><p>[<a href="/pubmed/19328630/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R3">Ref list</a>]</p></div><div id="body-link-popper-R4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Molecular epidemiology and its current clinical use in cancer management.<div class="authors">Hartman M, Loy EY, Ku CS, Chia KS</div><div class="citation">Lancet Oncol. 2010 Apr; 11(4):383-90.</div><p>[<a href="/pubmed/20359664/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R4">Ref list</a>]</p></div><div id="body-link-popper-R5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div><div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div><p>[<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R5">Ref list</a>]</p></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The use of genomic information to optimize cancer chemotherapy.<div class="authors">Innocenti F, Cox NJ, Dolan ME</div><div class="citation">Semin Oncol. 2011 Apr; 38(2):186-95.</div><p>[<a href="/pubmed/21421109/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R6">Ref list</a>]</p></div><div id="body-link-popper-R7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).<div class="authors">Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM</div><div class="citation">J Clin Oncol. 2010 Aug 1; 28(22):3617-22.</div><p>[<a href="/pubmed/20606091/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R7">Ref list</a>]</p></div><div id="body-link-popper-R8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.<div class="authors">Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG</div><div class="citation">J Natl Cancer Inst. 2000 Feb 2; 92(3):205-16.</div><p>[<a href="/pubmed/10655437/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R8">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Japanese single nucleotide polymorphism database for 267 possible drug-related genes.<div class="authors">Iida A, Saito S, Sekine A, Takahashi A, Kamatani N, Nakamura Y</div><div class="citation">Cancer Sci. 2006 Jan; 97(1):16-24.</div><p>[<a href="/pubmed/16367916/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R9">Ref list</a>]</p></div><div id="body-link-popper-R10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Principal components analysis corrects for stratification in genome-wide association studies.<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div><div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div><p>[<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R10">Ref list</a>]</p></div><div id="body-link-popper-R11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.<div class="authors">Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, Wang HH, Yao A, Chen YT, Hsu CN</div><div class="citation">Nucleic Acids Res. 2006 Jul 1; 34(Web Server issue):W635-41.</div><p>[<a href="/pubmed/16845089/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R11">Ref list</a>]</p></div><div id="body-link-popper-R12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.<div class="authors">Li L, Fridley BL, Kalari K, Jenkins G, Batzler A, Weinshilboum RM, Wang L</div><div class="citation">PLoS One. 2009 Nov 9; 4(11):e7765.</div><p>[<a href="/pubmed/19898621/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R12">Ref list</a>]</p></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">13. <span class="element-citation">R Development Core Team. A language and environment for statistical computing [Internet] <span></span> [updated 2006 April 21; cited 2010 July 7]. Available from:  <a href="http://www.R-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.R-project.org</a>.</span> [<a href="#R13">Ref list</a>]</div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">14. <span class="element-citation">Therneau TM, Grambsch PM.  <span class="ref-journal">Modeling survival data: extending the Cox model.</span> New York: Springer; 2000.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Modeling+survival+data:+extending+the+Cox+model&amp;author=TM+Therneau&amp;author=PM+Grambsch&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="#R14">Ref list</a>]</div><div id="body-link-popper-R33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">33. <span class="element-citation">Illumina. "TOP/BOT" strand and "A/B" allele: A guide to Illumina's method for determining Strand and Allele for the GoldenGate and Infinium Assays [Internet] <span></span> [updated 2006 June 27; cited 2010 December 23]. Available from:  <a href="http://www.illumina.com/documents/products/technotes/technote_topbot.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.illumina.com/documents/products/technotes/technote_topbot.pdf</a>.</span> [<a href="#R33">Ref list</a>]</div><div id="body-link-popper-R32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">SCAN: SNP and copy number annotation.<div class="authors">Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, Dolan ME, Cox NJ</div><div class="citation">Bioinformatics. 2010 Jan 15; 26(2):259-62.</div><p>[<a href="/pubmed/19933162/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R32">Ref list</a>]</p></div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity.<div class="authors">Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, Maeda Y, Fukui Y, Konno S, Huang SK, Nishimura M, Adachi M</div><div class="citation">J Allergy Clin Immunol. 2006 Apr; 117(4):795-801.</div><p>[<a href="/pubmed/16630936/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production.<div class="authors">Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R</div><div class="citation">J Immunol. 2001 Oct 15; 167(8):4137-40.</div><p>[<a href="/pubmed/11591732/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R16">Ref list</a>]</p></div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis.<div class="authors">Xie Y, Sheng W, Xiang J, Ye Z, Yang J</div><div class="citation">Cancer Invest. 2010 Jul; 28(6):598-607.</div><p>[<a href="/pubmed/20210523/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R17">Ref list</a>]</p></div><div id="body-link-popper-R18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia.<div class="authors">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H</div><div class="citation">Int J Mol Med. 2007 Nov; 20(5):717-23.</div><p>[<a href="/pubmed/17912466/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R18">Ref list</a>]</p></div><div id="body-link-popper-R19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.<div class="authors">Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H</div><div class="citation">J Clin Immunol. 2008 Jan; 28(1):44-9.</div><p>[<a href="/pubmed/17828618/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R19">Ref list</a>]</p></div><div id="body-link-popper-R20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pathways for aberrant angiogenesis in pancreatic cancer.<div class="authors">Korc M</div><div class="citation">Mol Cancer. 2003 Jan 7; 2():8.</div><p>[<a href="/pubmed/12556241/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R20">Ref list</a>]</p></div><div id="body-link-popper-R21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> WWOX: its genomics, partners, and functions.<div class="authors">Del Mare S, Salah Z, Aqeilan RI</div><div class="citation">J Cell Biochem. 2009 Nov 1; 108(4):737-45.</div><p>[<a href="/pubmed/19708029/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R21">Ref list</a>]</p></div><div id="body-link-popper-R22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.<div class="authors">Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA</div><div class="citation">Prostate. 2009 Mar 1; 69(4):385-91.</div><p>[<a href="/pubmed/19035517/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R22">Ref list</a>]</p></div><div id="body-link-popper-R23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.<div class="authors">Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, Chiecchio L, Dachs Cabanas E, Dagrada GP, Nightingale M, Protheroe RK, Stockley D, Else M, Dickens NJ, Cross NC, Davies FE, Morgan GJ</div><div class="citation">Blood. 2007 Nov 1; 110(9):3291-300.</div><p>[<a href="/pubmed/17609426/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R23">Ref list</a>]</p></div><div id="body-link-popper-R24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Multiple genetic loci modulate lung adenocarcinoma clinical staging.<div class="authors">Frullanti E, Galvan A, Falvella FS, Manenti G, Colombo F, Vannelli A, Incarbone M, Alloisio M, Nosotti M, Santambrogio L, Gonzalez-Neira A, Pastorino U, Dragani TA</div><div class="citation">Clin Cancer Res. 2011 Apr 15; 17(8):2410-6.</div><p>[<a href="/pubmed/21242121/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R24">Ref list</a>]</p></div><div id="body-link-popper-R25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers.<div class="authors">Gerstein AV, Almeida TA, Zhao G, Chess E, Shih IeM, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N</div><div class="citation">Genes Chromosomes Cancer. 2002 May; 34(1):9-16.</div><p>[<a href="/pubmed/11921277/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R25">Ref list</a>]</p></div><div id="body-link-popper-R27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.<div class="authors">Müerköster S, Arlt A, Sipos B, Witt M, Grossmann M, Klöppel G, Kalthoff H, Fölsch UR, Schäfer H</div><div class="citation">Cancer Res. 2005 Feb 15; 65(4):1316-24.</div><p>[<a href="/pubmed/15735017/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R27">Ref list</a>]</p></div><div id="body-link-popper-R28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.<div class="authors">Pan X, Arumugam T, Yamamoto T, Levin PA, Ramachandran V, Ji B, Lopez-Berestein G, Vivas-Mejia PE, Sood AK, McConkey DJ, Logsdon CD</div><div class="citation">Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.</div><p>[<a href="/pubmed/19088029/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R28">Ref list</a>]</p></div><div id="body-link-popper-R29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines.<div class="authors">Guo X, Xu B, Pandey S, Goessl E, Brown J, Armesilla AL, Darling JL, Wang W</div><div class="citation">Cancer Lett. 2010 Apr 1; 290(1):104-13.</div><p>[<a href="/pubmed/19782464/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R29">Ref list</a>]</p></div><div id="body-link-popper-R30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.<div class="authors">Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ</div><div class="citation">J Clin Oncol. 2009 May 1; 27(13):2231-7.</div><p>[<a href="/pubmed/19307500/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R30">Ref list</a>]</p></div><div id="body-link-popper-R31" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.<div class="authors">Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD, ECOG 2100.</div><div class="citation">J Clin Oncol. 2008 Oct 1; 26(28):4672-8.</div><p>[<a href="/pubmed/18824714/" ref="reftype=pubmed&amp;article-id=3412624&amp;issue-id=212764&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R31">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T08:15:42-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CB9E0DD53BE810000000000630041&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3412624%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3412624/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>